CN101164583B - 治疗上皮糜烂的复合制剂及其制备方法 - Google Patents
治疗上皮糜烂的复合制剂及其制备方法 Download PDFInfo
- Publication number
- CN101164583B CN101164583B CN200610063142.8A CN200610063142A CN101164583B CN 101164583 B CN101164583 B CN 101164583B CN 200610063142 A CN200610063142 A CN 200610063142A CN 101164583 B CN101164583 B CN 101164583B
- Authority
- CN
- China
- Prior art keywords
- aloe
- compound formulation
- yellow sap
- matter
- dry product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 230000003628 erosive effect Effects 0.000 title claims abstract description 36
- 150000001875 compounds Chemical class 0.000 title claims abstract description 35
- 238000009472 formulation Methods 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 241001116389 Aloe Species 0.000 claims abstract description 77
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 75
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 19
- 239000000969 carrier Substances 0.000 claims abstract description 13
- 230000003232 mucoadhesive effect Effects 0.000 claims abstract description 13
- 238000005507 spraying Methods 0.000 claims abstract description 13
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 8
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims abstract description 8
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims abstract description 8
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920000148 Polycarbophil calcium Polymers 0.000 claims abstract description 7
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 7
- 229920002000 Xyloglucan Polymers 0.000 claims abstract description 7
- 229940072056 alginate Drugs 0.000 claims abstract description 7
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 7
- 229920000615 alginic acid Polymers 0.000 claims abstract description 7
- 229960001631 carbomer Drugs 0.000 claims abstract description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 7
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000001814 pectin Substances 0.000 claims abstract description 7
- 235000010987 pectin Nutrition 0.000 claims abstract description 7
- 229920001277 pectin Polymers 0.000 claims abstract description 7
- 229960000292 pectin Drugs 0.000 claims abstract description 7
- 229950005134 polycarbophil Drugs 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 230000000840 anti-viral effect Effects 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 108700028325 pokeweed antiviral Proteins 0.000 claims description 12
- 239000003223 protective agent Substances 0.000 claims description 10
- 230000004071 biological effect Effects 0.000 claims description 9
- 239000000829 suppository Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 102000008070 Interferon-gamma Human genes 0.000 claims description 6
- 108010074328 Interferon-gamma Proteins 0.000 claims description 6
- 238000013270 controlled release Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- -1 electuary Substances 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 229960003130 interferon gamma Drugs 0.000 claims description 6
- 229940040145 liniment Drugs 0.000 claims description 6
- 239000000865 liniment Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 238000013268 sustained release Methods 0.000 claims description 6
- 239000012730 sustained-release form Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 150000004056 anthraquinones Chemical class 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- RZPFVRFSYMUDJO-UHFFFAOYSA-N 2h-naphthalen-1-one Chemical compound C1=CC=C2C(=O)CC=CC2=C1 RZPFVRFSYMUDJO-UHFFFAOYSA-N 0.000 claims description 4
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 2
- 244000101643 Aloe ferox Species 0.000 claims description 2
- 235000015858 Aloe ferox Nutrition 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 244000186892 Aloe vera Species 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 abstract description 7
- 201000009030 Carcinoma Diseases 0.000 abstract description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 3
- 210000001126 granulation tissue Anatomy 0.000 abstract description 3
- 206010020718 hyperplasia Diseases 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 231100000820 toxicity test Toxicity 0.000 abstract description 3
- 210000001215 vagina Anatomy 0.000 abstract description 3
- 208000035143 Bacterial infection Diseases 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 abstract description 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 2
- 239000011149 active material Substances 0.000 abstract 2
- 230000001900 immune effect Effects 0.000 abstract 2
- 210000004999 sex organ Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 6
- 241000701806 Human papillomavirus Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 206010008263 Cervical dysplasia Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000036142 Viral infection Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 3
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 3
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 3
- 210000003679 cervix uteri Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 208000007117 Oral Ulcer Diseases 0.000 description 2
- 206010040840 Skin erosion Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 201000003988 chronic cervicitis Diseases 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 206010014181 Ectropion of cervix Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000304370 Orostachys Species 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 239000010103 Podophyllin Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 201000010442 acute cervicitis Diseases 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 150000008425 anthrones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 108700004675 bleomycetin Proteins 0.000 description 1
- QYOAUOAXCQAEMW-UTXKDXHTSA-N bleomycin A5 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCCNCCCCN)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C QYOAUOAXCQAEMW-UTXKDXHTSA-N 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 229940068582 podophyllin Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 210000005125 simple columnar epithelium Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000014221 sudden cardiac arrest Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610063142.8A CN101164583B (zh) | 2006-10-16 | 2006-10-16 | 治疗上皮糜烂的复合制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610063142.8A CN101164583B (zh) | 2006-10-16 | 2006-10-16 | 治疗上皮糜烂的复合制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101164583A CN101164583A (zh) | 2008-04-23 |
CN101164583B true CN101164583B (zh) | 2016-01-27 |
Family
ID=39333537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610063142.8A Active CN101164583B (zh) | 2006-10-16 | 2006-10-16 | 治疗上皮糜烂的复合制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101164583B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2163240A1 (en) * | 2008-09-12 | 2010-03-17 | Universita' Degli Studi Di Genova | A method for the production of bioadhesive compact matrices |
CN102008628B (zh) * | 2009-09-08 | 2014-04-09 | 海南森瑞谱生命科学药业股份有限公司 | 用于治疗女性生殖道病毒感染的药物及其缓释制剂的制备方法 |
CN101773516B (zh) * | 2009-11-26 | 2011-06-08 | 上海华拓医药科技发展股份有限公司 | 一种阴道用酸性缓冲凝胶制剂及其制备方法和应用 |
EP2811982A1 (en) * | 2012-02-08 | 2014-12-17 | University Of The Witwatersrand, Johannesburg | Pharmaceutical dosage form |
CN104353058B (zh) * | 2014-10-14 | 2016-12-07 | 海南森瑞谱生命科学药业股份有限公司 | 商陆抗病毒蛋白冻干粉复合剂及其制备方法 |
CN106075001A (zh) * | 2016-08-13 | 2016-11-09 | 广州婕熹卡生物科技有限公司 | 含龙血竭多酚的水溶性凝胶及其在治疗宫颈糜烂药物上的用途 |
CN108514640A (zh) * | 2018-05-11 | 2018-09-11 | 江苏森瑞谱生物制药有限公司 | 含商陆抗病毒蛋白和免疫活性物质的药物组合物及其用途 |
CN109364241A (zh) * | 2018-10-18 | 2019-02-22 | 武汉华扬动物药业有限责任公司 | 一种催产素栓剂及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1377698A (zh) * | 2002-04-22 | 2002-11-06 | 武汉大学 | 纳米芦荟妇洁护理露及其制备方法 |
-
2006
- 2006-10-16 CN CN200610063142.8A patent/CN101164583B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1377698A (zh) * | 2002-04-22 | 2002-11-06 | 武汉大学 | 纳米芦荟妇洁护理露及其制备方法 |
Non-Patent Citations (1)
Title |
---|
芦荟汁治疗宫颈糜烂18例的疗效观察;王旭阳,等;《吉林医学信息》;19971231(第4期);39 * |
Also Published As
Publication number | Publication date |
---|---|
CN101164583A (zh) | 2008-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101164583B (zh) | 治疗上皮糜烂的复合制剂及其制备方法 | |
CN102008628B (zh) | 用于治疗女性生殖道病毒感染的药物及其缓释制剂的制备方法 | |
CN103721131B (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
CN102091203A (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN102058781A (zh) | 用于治疗烧烫伤的中药膜剂 | |
CN103223061A (zh) | 一种褥疮外用药及其制备方法 | |
CN104127685A (zh) | 一种外用药膏组合物在制备用于治疗皮肤创伤药物中的应用 | |
WO2020010919A1 (zh) | 一种中药组合物、中药复方制剂及其制备方法和应用 | |
CN113616714A (zh) | 一种高硒抗hpv病毒的生物蛋白凝胶敷料及其制备方法 | |
CN109276703A (zh) | 植物抗病毒蛋白复合剂及其制备方法 | |
CN103520439B (zh) | 一种治疗热毒蕴结型慢性骨髓炎的中药及其制备方法 | |
CN102784299A (zh) | 促进伤口愈合不留瘢痕色素的外用膏及其制备方法 | |
CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
CN102133379A (zh) | 一种治疗妇科病的中药丸 | |
CN114903944A (zh) | 一种改善宫颈hpv感染症状的组合物、制剂及制备方法 | |
CN106177156A (zh) | 一种防治牛传染性鼻气管炎的中药组合物及其应用 | |
CN116270940B (zh) | 一种防治hpv病毒感染的中药组合物及其制备方法和应用 | |
CN101612203B (zh) | 一种用于治疗尖锐湿疣的中药组合物及其应用 | |
CN110882346A (zh) | 一种藏药药剂及其制备方法 | |
CN108553605A (zh) | 一种治疗慢性盆腔炎的中药颗粒剂及其制备工艺 | |
CN109248244A (zh) | 一种治疗妇科炎症的中药及其制备方法 | |
CN108653077A (zh) | 一种草本祛痘膏及其制备方法 | |
CN102671069B (zh) | 一种治疗变应性鼻炎的药物组合物 | |
CN1374095A (zh) | 治疗烧伤的药物及其制作方法 | |
CN103341151B (zh) | 用于治疗慢性支气管炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Shenzhen Longyang BIology Technologies Co.,Ltd. Document name: Notice of non patent agency |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Shenzhen Longyang BIology Technologies Co.,Ltd. Document name: Correction notice |
|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 570000 No.5, Yaogu 1st Road, national high tech Industrial Park, Haikou City, Hainan Province Patentee after: Senruipu Life Science Pharmaceutical (Hainan) Group Co.,Ltd. Address before: The construction of gold industrial zone three cross road in Hainan Province, Haikou Jinma Arts crafts emporium 5-A Patentee before: HAINAN SR-BIOPHARMA CO.,LTD. |
|
CP03 | Change of name, title or address |